National Nurses Week May 6 – 12, 2022 – Honor Thy Nurse

National Nurses Week begins each year on May 6th and ends on May 12th. It coincides with Florence Nightingale’s birthday on May 12). Since 1896, the nursing profession has been supported by the American Nurses Association.

Heroes

Our nurses are heroes. They are the backbone of our American Health Care system taking care of patients of all ages. Nurses perform difficult tasks such as delivering babies, caring for the elderly, assisting in operating rooms, working in the intensive care and neo-natal units, or serve in an executive or administrative capacity. In addition to working inside hospitals, nursing homes, and acute facilities, nurses are employed by school districts to safeguard students.

Skilled

They are highly skilled trained professionals who work endless hours without a single complaint.

Continuing Medical Education

When it comes to continuing their medical education, nurses can take mobile courses (Jointly accredited by ANCC, ACCME, and ACPE) so they do not interrupt their work schedules. They are able to fulfill their state licensing renewal requirements with convenient self-paced courses.

Technology

As more and more nurses begin to experience burnout, this is beginning to show a shortage in frontline nurses across the board. This is not the result of the Covid pandemic but from years of poor systems within our hospitals. Nurses are forced to perform clerical duties, clean bedpans, and other services which do not fall within the scope of their profession.

More hospitals will have to focus on streamlining and automating the workflow while developing a stronger line of communication.  Health IT strategies can help align patients, beds, and staff to optimize productivity. Failure of hospitals to execute intelligent IT solutions will further deteriorate our health care system.  With the shortage of nurses, we are seeing mass burnout and staff turnover.

Conclusion

If we are to keep our nurses happy, then institutions need to start listening and developing systems to ease the stress they feel every day.  To all our nurses, wherever you are, we salute you during National Nurse’s week and every day you are on the job!

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”